D145E is a point mutation on troponin C that leads to hypertrophic cardiomyopathy disease. This mutation is caused by the change of nucleotide C to A at nucleotide 435,[1] switching the amino acid aspartic acid to glutamic acid, which is located at the C-terminal tail.[2] Patients with this mutation have different structure on the thin filament and alter the binding of Ca2+ at the troponin C site IV.[1][3] Further, D145E causes increase in development of force and activation of ATPase in the presence of Ca2+.[4]
^Kalyva, Athanasia; Parthenakis, Fragiskos I.; Marketou, Maria E.; Kontaraki, Joanna E.; Vardas, Panos E. (2014-04-01). "Biochemical characterisation of Troponin C mutations causing hypertrophic and dilated cardiomyopathies". Journal of Muscle Research and Cell Motility. 35 (2): 161–178. doi:10.1007/s10974-014-9382-0. ISSN1573-2657. PMID24744096. S2CID1726747.